Stock Pricing vs Patent Signaling: Evidence from China’s NEEQ
Mon, May 10, 2021
Speaker: BI Ruigang
Date: 12:00-13:00, May. 11th, 2021
Venue: Room 306, Tongji Building A
Abstract:
Is the number of patent application a reasonable measurement of innovation ability or only a signal for startups? This question delivers important policy implication but receive little attention in the literature. By exploiting an exogenous policy shock that improves the stock liquidity and thus relatively lowers the patents’ signal value, we show that while the startups in the treatment group patented less after the liquidity shock, they experienced no decrease in R&D investment. Therefore, the result highlights the signaling value of patents for startups and call caution to the use of patent applications to measure innovation performance in startups.
We protect your privacy. We use cookies to personalize content, provide features, and analyze traffic to our website anonymously and in a privacy compliant manner. By law, we may store cookies on your device if they are strictly necessary for the operation of this site. For all other cookie types, we need your permission. For more information, please see the privacy policy linked below.